I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Tamiya, Motohiro
239
results:
Search for persons
X
Format
Online (239)
Mediatypes
Articles (Online) (127)
Bookchapter (Online) (2)
OpenAccess-fulltext (110)
Sorted by: Relevance
Sorted by: Year
?
1
Potent CTLs can be induced against tumor cells in an enviro..:
Mizote, Yu
;
Inoue, Takako
;
Akazawa, Takashi
...
Cancer Science. 115 (2024) 4 - p. 1114-1128 , 2024
Link:
https://doi.org/10.1111/..
?
2
Prognostic impact of clinical factors for immune checkpoint..:
Takei, Shota
;
Kawachi, Hayato
;
Yamada, Tadaaki
...
Frontiers in Immunology. 15 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
3
Prophylactic pegfilgrastim reduces febrile neutropenia in r..:
Miura, Keita
;
Yamaguchi, Ou
;
Mori, Keita
...
Scientific Reports. 14 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
4
Risk Stratification According to Baseline and Early Change ..:
Matsumoto, Kinnosuke
;
Yamamoto, Yuji
;
Shiroyama, Takayuki
...
Targeted Oncology. , 2024
Link:
https://doi.org/10.1007/..
?
5
Real-world outcomes of nivolumab plus ipilimumab and pembro..:
Matsumoto, Kinnosuke
;
Shiroyama, Takayuki
;
Tamiya, Motohiro
...
Cancer Immunology, Immunotherapy. 73 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1007/..
?
6
Feasibility of atezolizumab and bevacizumab combination reg..:
Nakabori, Tasuku
;
Kunimasa, Kei
;
Kawabata, Masaki
...
Cancer Medicine. 13 (2024) 12 - p. , 2024
Link:
https://doi.org/10.1002/..
?
7
Phase II Study of the Liposomal Formulation of Eribulin (E7..:
Nishio, Makoto
;
Murakami, Shuji
;
Kawakami, Hisato
...
Cancer Research Communications. 4 (2024) 1 - p. 226-235 , 2024
Link:
https://doi.org/10.1158/..
?
8
A DPC Database Study on the Safety of Atezolizumab/Carbopla..:
Tamiya, Motohiro
;
Iwasawa, Shunichiro
;
Sasaki, Yusuke
..
Advances in Therapy. , 2024
Link:
https://doi.org/10.1007/..
?
9
Artemis: A Multicenter, Open-Label, Single-Arm, Phase II St..:
Okuma, Yusuke
;
Nomura, Shogo
;
Sakakibara-Konishi, Jun
...
Clinical Lung Cancer. 25 (2024) 4 - p. 389-394 , 2024
Link:
https://doi.org/10.1016/..
?
10
Clinical application of the Lung Cancer Compact PanelTM usi..:
Kunimasa, Kei
;
Tamiya, Motohiro
;
Inoue, Takako
...
Lung Cancer. 189 (2024) - p. 107498 , 2024
Link:
https://doi.org/10.1016/..
?
11
Exceptionally long‐lasting response to dabrafenib plus tram..:
Inoue, Takako
;
Kunimasa, Kei
;
Tamiya, Motohiro
...
Thoracic Cancer. 15 (2024) 11 - p. 929-933 , 2024
Link:
https://doi.org/10.1111/..
?
12
Machine learning analysis of pathological images to predict..:
Shibaki, Ryota
;
Fujimoto, Daichi
;
Nozawa, Tsukasa
...
Journal for ImmunoTherapy of Cancer. 12 (2024) 2 - p. e007987 , 2024
Link:
https://doi.org/10.1136/..
?
13
A Retrospective, Multicenter, Observational Study to Evalua..:
Goto, Yasushi
;
Kenmotsu, Hirotsugu
;
Tamiya, Motohiro
...
JTO Clinical and Research Reports. 4 (2023) 5 - p. 100508 , 2023
Link:
https://doi.org/10.1016/..
?
14
Multicentre real-world data of ramucirumab plus docetaxel a..:
Nakamura, Atsushi
;
Yamaguchi, Ou
;
Mori, Keita
...
European Journal of Cancer. 184 (2023) - p. 62-72 , 2023
Link:
https://doi.org/10.1016/..
?
15
Corrigendum to "Osimertinib as first-line treatment for eld..:
Sakata, Yoshihiko
;
Saito, Go
;
Sakata, Shinya
...
Lung Cancer. , 2023
Link:
https://doi.org/10.1016/..
1-15